drugs acting on the cardiovascular system · drugs acting on the cardiovascular system akos...
TRANSCRIPT
Drugs acting on the cardiovascular system
Akos Jerzsele DVM
Antiarrhytmic drugs
Arrhythmia, dysrhythmia:
1. Ectopic impulse!
2. Cardiomyopathy
3. Re-entry
4. Drugs
5. Electrolite imbalances
6. Primary cause
Vaughan-Williams conductance
Group
I. Na-channel blockers
("membrane-stabilizers")
II. Beta receptor blockers
III Potassium channel blockers
IV. Calcium channel blockers
V. Other substances
Digoxin, atropine
I. class antiarrhythmic drugs
Na-channel blockers (membrane stabilizers)
Open inactive state!
Myocardial cells
I.A. e.g. quinidine
I.B. e.g. lidocaine
I.C. e.g. flecainide
ERP= effective refractory period
Quinidine
Vagal effect (+direct effect!)
Negative inotropic (heart failure!)
Dog (GI and CV side effects), cat (short t1/2) ??
Horse IV. or PO.
frequent side effects
supraventricular arrhytmias
I. A. class antiarrhythmic drugs
Procainamide
Side effect (IV.) negative inotropic, arrhytmogenic
Unfavorable pharmacokinetics (short t1/2)
Ventricular arrhytmias IV. if refractory to lidocaine
I. A. class antiarrhythmic drugs
LidocaineImmediate treatment of life threatening ventricular arrhytmias!
Supraventricular effect
Advantages
Short t1/2
Damaged cells normal cells
Hypokalaemia reduces effect
Pharmacokinetics
orally? (first pass)
intravenously
2-4 mg/kg loading dose, then continous infusion (Ca)
0,25-0,75 mg/kg iv., then cont. inf. (Fe)
I. B. class antiarrhythmic drugs
LidocaineSide effects (Fe!)
CNS ( diazepam)
heart (sick sinus syndrome)
negative inotropic effect, hypotension, conductance failure safe to use
I. B. class antiarrhythmic drugs
MexiletineTreatment of ventricularis arrhytmias at home! (DCM, HCM)
Similar characteristics to lidocaine
Can be given orally (F=85%)
Rare side effects (GI, CNS)
5-10 mg/kg per os TID
Frequently combined with β-blockers (atenolole, sotalole)
I. B. class antiarrhythmic drugs
„Beta-blockers”
=β-receptor antagonists
Catecholamines frequency, conductance, refractory period
Indications
1. Supraventricular and ventricular arrhytmias
preventing sudden death
2. HCM
3. Hyperthyroidism, methylxanthine poisoning
Contraindications (severe bradycardia, AV-block)
II. Class antiarrhythmic drugs
1. generation (β1 + β2)
Propranolol
2. generation (β1)
Metoprolol
Atenolol
Esmolol (short t1/2)
3. generation (β1 + peripherial + !)
Carvedilol
slowly developing effect
II. class antiarrhytmic drugs
Ca: combination with mexiletine
III. class antiarrhytmic drugs
K+ channel blockers ERP increases! excellent in re-entry
III. class drugs
Sotalol
excellent in boxer cardiomyopathy
Amiodarone
I+II+III+IV effects!
supraventricular + ventricular
IV. class antiarrhytmic drugs
Ca2+ channel blockers
SA-node and AV-node! bradycardia
Mainly supraventricular
Decreased Ca2+-influx decreased contraction and vasodilatation!!
1. Dihydropyridine type (vessels) amlodipine, nifedipine
2. Non-dihydropyridine type (heart) verapamil, diltiazem
Verapamil (negative inotropic structural deficiencies)
Diltiazem
Heart failure
Congestive heart failure (CHF)
Acute heart failure
cause: sudden deterioration of heart pump function (e.g. myocardial infarction, ventricular fibrillation)
Chronic heart failure
cause: gradual and slow deterioration in heart pump function and performance
Heart failure
Factors affecting heart performance
CONTRACTILITY
AFTERLOAD
~ peripherial resistance
PRELOAD
~ blood inflow into atria
+ FREQUENCY
Treatment options of CHF
1. Increasing frequency: only in life threatening cases!
e.g. epinephrine positive inotropic, chronotropic increases myocardial oxygen demand
Treatment options of CHF
2. Increasing contractility: digitalis glycosides
3. Decreasing preload and afterload: ACE inhibitors
4. Inodilators (2+3): PDE inhibitors
5. Vasoactive substances (arterial and venous vasodilators): e.g. nitroglycerine
6. Diuretics: decrease preload
Positive inotropic drugs, cardiotonics
Cardiotonics
In acute heart failure
Epinephrine
Dobutamine
Dopamine
Cardiotonics
In chronic heart failure
Digitalis glycosides
Pimobendan
Digitalis glycosides = cardiac glycosides
Digitalis purpurea Digitalis lanata
Digitoxin Digoxin
Cardiotonics
Pharmacological effects
1. direct cardiac action
positive inotropic cardiac output
improves RBF water and Na+ excretion
2. increases vagal tone
negative chronotropic
negative dromotropic
CardiotonicsDigitoxin, strofantine
Digoxin
pharmacokinetics
orally
protein binding interactions!
accumulation in myocytes
measuring plasma levels after 3-5 days
excretion via kidney
small therapeutic index (hypokalaemia!)
CardiotonicsDigoxin
small therapeutic index
side effects:
cardiac: arrhythmias, bradycardia (lidocaine, Digibind®)
hypokalaemia!
extracardial: GI-signs (vomiting)
CardiotonicsDigoxin
Usage
prolong survival time in heart failure
supraventricular tachyarrhytmias
Contraindication
outflow obstruction (HCM, stenosis)
Initial dosage 5-10 µg/kg per os BID
6+1 days
PDE inhibitors
PDE inhibitors
Pimobendan (Vetmedin A.U.V.)Multiple mechanisms:
• Phosphodiesterase (PDE3) inhibition cAMP accumulated in myocardial cells Ca2+ concentration positive inotropic effect
• Ca2+ sensitizer positive inotropic effect
• PDE inhibition arterial and venous vasodilation
= „INODILATOR”
Oxygen consumption is not increased!
Contraindicatedoutflow obstruction (HCM, stenosis)
Kinetics: per os, bioavailability (feeding!)
Extensive protein binding!
Side effects?
D: 0,1-0,3 mg/kg BID po.
PDE inhibitorsPimobendan
Pharmacology of volume regulation and vasoregulation
Angiotensin convertase enzyme (ACE) inhibitors
ACE inhibitors – captoprilBothrops jararaca
ACE inhibitors
Mechanism of effect
decrease in blood RBF
angiotensinogen (liver)
Renin
angiotensin-I
ACE
angiotensin-II
Vasoconstriction Aldosterone ADH Salt hunger, thirst
(20x epinephrine)
inactivatesbradykinin!
ACE inhibitors
Pharmacological effects
• arterial vasodilation peripherial resistance, afterload
• venodilation CVP decreases preload
• water excretion preload
• does not alter contractility (but…)
Heart performance INCREASES!
+ decrease blood pressure
ACE inhibitors
Indications
• heart failure (species!)
• hypertension
• proteinuria
ACE inhibitors
Pharmacokinetics
• oral administration good absorption ( captopril)
• metabolism: enalapril enalaprilat,
benazepril benazeprilat
ramipril ramiprilat
• Onset of action: approx. 4-6 hours
• Duration of action: approx. 12-14 hours (ramipril, enalapril)
• 12-24 hours benazepril, lisinopril
• lisinopril no activation in liver
• excretion: kidney (chronic renal failure!), but benazepril…
ACE inhibitors
Side effects
• azotaemia (LD50=100-200 mg/kg)
• blood biochemistry!
• hypotension tiredness, faintness! (humansdogs)
• GI-disturbances: anorexia, vomiting, diarrhea
• Ho: dry cough
ACE inhibitorsCaptopril
Enalapril
D: 0,5 mg/kg BID or SID
Ramipril
similar attributes ~ enalapril
D: 0,125 mg/kg BID or SID
Benazepril
D: 0,25 – 0,5 mg/kg
SID usage preferred, 50-50% kidney-liver
Lisinopril
not activated in liver hepatic failure!
Angiotensin II receptor antagonists
Advantages
more effective
no bradykinin activation
Losartan, valsartan, telmisartan